

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sulfate transmembrane transport (GO:1902358) | 7.45866929 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.39487363 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.39487363 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 7.07256992 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.07256992 |
| 6 | aromatic amino acid family catabolic process (GO:0009074) | 6.63588363 |
| 7 | sulfate transport (GO:0008272) | 6.24187730 |
| 8 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.03555227 |
| 9 | tryptophan catabolic process (GO:0006569) | 5.98082712 |
| 10 | indole-containing compound catabolic process (GO:0042436) | 5.98082712 |
| 11 | indolalkylamine catabolic process (GO:0046218) | 5.98082712 |
| 12 | kynurenine metabolic process (GO:0070189) | 5.84604192 |
| 13 | bile acid biosynthetic process (GO:0006699) | 5.72123312 |
| 14 | glyoxylate metabolic process (GO:0046487) | 5.69251593 |
| 15 | tryptophan metabolic process (GO:0006568) | 5.62346830 |
| 16 | thyroid gland development (GO:0030878) | 5.59694778 |
| 17 | urea metabolic process (GO:0019627) | 5.45212842 |
| 18 | urea cycle (GO:0000050) | 5.45212842 |
| 19 | alpha-linolenic acid metabolic process (GO:0036109) | 5.38207640 |
| 20 | cysteine metabolic process (GO:0006534) | 5.35458337 |
| 21 | negative regulation of fibrinolysis (GO:0051918) | 5.26773893 |
| 22 | high-density lipoprotein particle remodeling (GO:0034375) | 5.26646981 |
| 23 | sulfur amino acid catabolic process (GO:0000098) | 5.26476166 |
| 24 | epoxygenase P450 pathway (GO:0019373) | 5.21240597 |
| 25 | protein carboxylation (GO:0018214) | 5.13709934 |
| 26 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.13709934 |
| 27 | regulation of fibrinolysis (GO:0051917) | 5.04392424 |
| 28 | nitrogen cycle metabolic process (GO:0071941) | 5.03231064 |
| 29 | complement activation, alternative pathway (GO:0006957) | 5.00066812 |
| 30 | serine family amino acid catabolic process (GO:0009071) | 4.95848685 |
| 31 | regulation of protein activation cascade (GO:2000257) | 4.94375483 |
| 32 | bile acid metabolic process (GO:0008206) | 4.88754254 |
| 33 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.86163965 |
| 34 | lysine metabolic process (GO:0006553) | 4.83421060 |
| 35 | lysine catabolic process (GO:0006554) | 4.83421060 |
| 36 | aromatic amino acid family metabolic process (GO:0009072) | 4.79840705 |
| 37 | homocysteine metabolic process (GO:0050667) | 4.69871580 |
| 38 | regulation of cholesterol esterification (GO:0010872) | 4.69060393 |
| 39 | amino-acid betaine metabolic process (GO:0006577) | 4.68242111 |
| 40 | * thyroid hormone generation (GO:0006590) | 4.67624871 |
| 41 | regulation of triglyceride catabolic process (GO:0010896) | 4.61165331 |
| 42 | regulation of complement activation (GO:0030449) | 4.61090261 |
| 43 | reverse cholesterol transport (GO:0043691) | 4.57140498 |
| 44 | tyrosine metabolic process (GO:0006570) | 4.56378726 |
| 45 | alpha-amino acid catabolic process (GO:1901606) | 4.54840616 |
| 46 | protein-lipid complex remodeling (GO:0034368) | 4.52872308 |
| 47 | macromolecular complex remodeling (GO:0034367) | 4.52872308 |
| 48 | plasma lipoprotein particle remodeling (GO:0034369) | 4.52872308 |
| 49 | negative regulation of cholesterol transport (GO:0032375) | 4.46385854 |
| 50 | negative regulation of sterol transport (GO:0032372) | 4.46385854 |
| 51 | cellular ketone body metabolic process (GO:0046950) | 4.45850509 |
| 52 | phospholipid efflux (GO:0033700) | 4.36320299 |
| 53 | triglyceride homeostasis (GO:0070328) | 4.33716577 |
| 54 | acylglycerol homeostasis (GO:0055090) | 4.33716577 |
| 55 | drug metabolic process (GO:0017144) | 4.32739109 |
| 56 | oxidative demethylation (GO:0070989) | 4.29609180 |
| 57 | cellular amino acid catabolic process (GO:0009063) | 4.22311864 |
| 58 | drug catabolic process (GO:0042737) | 4.21753741 |
| 59 | indolalkylamine metabolic process (GO:0006586) | 4.21029594 |
| 60 | bile acid and bile salt transport (GO:0015721) | 4.19436865 |
| 61 | glutamate metabolic process (GO:0006536) | 4.19158575 |
| 62 | coenzyme catabolic process (GO:0009109) | 4.17977697 |
| 63 | cellular glucuronidation (GO:0052695) | 4.17264319 |
| 64 | glycine metabolic process (GO:0006544) | 4.16467337 |
| 65 | plasma lipoprotein particle clearance (GO:0034381) | 4.15957558 |
| 66 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 4.12764383 |
| 67 | ethanol oxidation (GO:0006069) | 4.12306927 |
| 68 | cellular biogenic amine catabolic process (GO:0042402) | 4.10014721 |
| 69 | amine catabolic process (GO:0009310) | 4.10014721 |
| 70 | cellular modified amino acid catabolic process (GO:0042219) | 4.09740411 |
| 71 | serine family amino acid metabolic process (GO:0009069) | 4.08658771 |
| 72 | benzene-containing compound metabolic process (GO:0042537) | 4.05775966 |
| 73 | cholesterol efflux (GO:0033344) | 4.02753758 |
| 74 | omega-hydroxylase P450 pathway (GO:0097267) | 4.01577180 |
| 75 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.00417285 |
| 76 | * thyroid hormone metabolic process (GO:0042403) | 3.99492154 |
| 77 | imidazole-containing compound metabolic process (GO:0052803) | 3.96809003 |
| 78 | arginine metabolic process (GO:0006525) | 3.89521605 |
| 79 | serine family amino acid biosynthetic process (GO:0009070) | 3.88477006 |
| 80 | aldehyde catabolic process (GO:0046185) | 3.88424517 |
| 81 | ketone body metabolic process (GO:1902224) | 3.85239369 |
| 82 | short-chain fatty acid metabolic process (GO:0046459) | 3.83623157 |
| 83 | alkaloid metabolic process (GO:0009820) | 3.83012224 |
| 84 | low-density lipoprotein particle remodeling (GO:0034374) | 3.80455249 |
| 85 | plasma lipoprotein particle assembly (GO:0034377) | 3.80411467 |
| 86 | glucuronate metabolic process (GO:0019585) | 3.75345408 |
| 87 | uronic acid metabolic process (GO:0006063) | 3.75345408 |
| 88 | fibrinolysis (GO:0042730) | 3.74339570 |
| 89 | S-adenosylmethionine metabolic process (GO:0046500) | 3.72478220 |
| 90 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.72234242 |
| 91 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.72234242 |
| 92 | carboxylic acid catabolic process (GO:0046395) | 3.70782921 |
| 93 | organic acid catabolic process (GO:0016054) | 3.70782921 |
| 94 | sulfur compound transport (GO:0072348) | 3.68638533 |
| 95 | exogenous drug catabolic process (GO:0042738) | 3.68391348 |
| 96 | acetyl-CoA metabolic process (GO:0006084) | 3.65349560 |
| 97 | cholesterol homeostasis (GO:0042632) | 3.64140435 |
| 98 | aspartate family amino acid catabolic process (GO:0009068) | 3.64081707 |
| 99 | regulation of bile acid biosynthetic process (GO:0070857) | 3.62524513 |
| 100 | positive regulation of lipid catabolic process (GO:0050996) | 3.62180361 |
| 101 | flavonoid metabolic process (GO:0009812) | 3.61466968 |
| 102 | cofactor catabolic process (GO:0051187) | 3.59511387 |
| 103 | negative regulation of lipase activity (GO:0060192) | 3.59375349 |
| 104 | sterol homeostasis (GO:0055092) | 3.59147316 |
| 105 | drug transmembrane transport (GO:0006855) | 3.58886147 |
| 106 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.58089400 |
| 107 | regulation of plasminogen activation (GO:0010755) | 3.57999303 |
| 108 | regulation of cholesterol homeostasis (GO:2000188) | 3.55720218 |
| 109 | urate metabolic process (GO:0046415) | 3.54060951 |
| 110 | phospholipid homeostasis (GO:0055091) | 3.51636933 |
| 111 | blood coagulation, intrinsic pathway (GO:0007597) | 3.50271125 |
| 112 | phenylpropanoid metabolic process (GO:0009698) | 3.37017645 |
| 113 | hormone biosynthetic process (GO:0042446) | 3.32854543 |
| 114 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.29130679 |
| 115 | cellular response to gonadotropin stimulus (GO:0071371) | 3.23954835 |
| 116 | sulfation (GO:0051923) | 3.22663869 |
| 117 | nephron tubule formation (GO:0072079) | 3.22448267 |
| 118 | hormone catabolic process (GO:0042447) | 3.15098382 |
| 119 | heme transport (GO:0015886) | 3.00370069 |
| 120 | L-fucose catabolic process (GO:0042355) | 2.99896519 |
| 121 | fucose catabolic process (GO:0019317) | 2.99896519 |
| 122 | L-fucose metabolic process (GO:0042354) | 2.99896519 |
| 123 | regulation of lipoprotein metabolic process (GO:0050746) | 2.98402151 |
| 124 | indole-containing compound metabolic process (GO:0042430) | 2.91222442 |
| 125 | amino acid salvage (GO:0043102) | 2.91179917 |
| 126 | L-methionine salvage (GO:0071267) | 2.91179917 |
| 127 | L-methionine biosynthetic process (GO:0071265) | 2.91179917 |
| 128 | positive regulation of fatty acid transport (GO:2000193) | 2.90287620 |
| 129 | * phenol-containing compound metabolic process (GO:0018958) | 2.88627869 |
| 130 | negative regulation of metanephros development (GO:0072217) | 2.85063258 |
| 131 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 2.81808484 |
| 132 | positive regulation of icosanoid secretion (GO:0032305) | 2.81327859 |
| 133 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.79610056 |
| 134 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.78397872 |
| 135 | reflex (GO:0060004) | 2.78089337 |
| 136 | vitamin biosynthetic process (GO:0009110) | 2.77851011 |
| 137 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.77304149 |
| 138 | xenobiotic catabolic process (GO:0042178) | 2.75657008 |
| 139 | phenol-containing compound catabolic process (GO:0019336) | 2.75426957 |
| 140 | negative regulation of hormone metabolic process (GO:0032351) | 2.74670213 |
| 141 | regulation of guanylate cyclase activity (GO:0031282) | 2.72910072 |
| 142 | response to pheromone (GO:0019236) | 2.71077869 |
| 143 | negative regulation of mesenchymal cell apoptotic process (GO:2001054) | 2.71003538 |
| 144 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.70662421 |
| 145 | behavioral response to nicotine (GO:0035095) | 2.68421366 |
| 146 | carnitine metabolic process (GO:0009437) | 2.67378045 |
| 147 | response to nitrosative stress (GO:0051409) | 2.66034777 |
| 148 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.64829804 |
| 149 | * hormone metabolic process (GO:0042445) | 2.61915514 |
| 150 | xenobiotic metabolic process (GO:0006805) | 2.54846115 |
| 151 | angiotensin maturation (GO:0002003) | 2.54160827 |
| 152 | dopamine transport (GO:0015872) | 2.49213453 |
| 153 | hydrogen peroxide catabolic process (GO:0042744) | 2.48400266 |
| 154 | intestinal absorption (GO:0050892) | 2.47657541 |
| 155 | ethanol metabolic process (GO:0006067) | 2.42464684 |
| 156 | transepithelial transport (GO:0070633) | 2.42441020 |
| 157 | arginine catabolic process (GO:0006527) | 2.42208024 |
| 158 | methionine biosynthetic process (GO:0009086) | 2.41295229 |
| 159 | positive regulation of guanylate cyclase activity (GO:0031284) | 2.40616859 |
| 160 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.40041279 |
| 161 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.40041279 |
| 162 | drug transport (GO:0015893) | 2.38814948 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.17141530 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.02152602 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.54400444 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.33424780 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.05133681 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.98891116 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.73400415 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.99635844 |
| 9 | * CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.62720811 |
| 10 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 3.10796384 |
| 11 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.07794193 |
| 12 | VDR_22108803_ChIP-Seq_LS180_Human | 2.54978582 |
| 13 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.50874381 |
| 14 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.34873770 |
| 15 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.30508644 |
| 16 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.26245042 |
| 17 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.21507269 |
| 18 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.17351263 |
| 19 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.04078181 |
| 20 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 2.03867132 |
| 21 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.02024810 |
| 22 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.5110832 |
| 23 | P300_19829295_ChIP-Seq_ESCs_Human | 1.98387943 |
| 24 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.96209823 |
| 25 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.94278972 |
| 26 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.90492466 |
| 27 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.89219704 |
| 28 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.80056347 |
| 29 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.79834016 |
| 30 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.78753663 |
| 31 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.78698051 |
| 32 | STAT3_23295773_ChIP-Seq_U87_Human | 1.66792007 |
| 33 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.63541809 |
| 34 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.63413583 |
| 35 | * FUS_26573619_Chip-Seq_HEK293_Human | 1.62543282 |
| 36 | AR_25329375_ChIP-Seq_VCAP_Human | 1.62424469 |
| 37 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.62359699 |
| 38 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.61903555 |
| 39 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.56589991 |
| 40 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.53965954 |
| 41 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.53098100 |
| 42 | TCF4_23295773_ChIP-Seq_U87_Human | 1.50975017 |
| 43 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.50166856 |
| 44 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.50166856 |
| 45 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.50097540 |
| 46 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.49754952 |
| 47 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.49329727 |
| 48 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.48543908 |
| 49 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.46936874 |
| 50 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.44649411 |
| 51 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.43746278 |
| 52 | EWS_26573619_Chip-Seq_HEK293_Human | 1.43665586 |
| 53 | GATA1_22025678_ChIP-Seq_K562_Human | 1.41591701 |
| 54 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.40613147 |
| 55 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.38369923 |
| 56 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.38263334 |
| 57 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.37181154 |
| 58 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.36301039 |
| 59 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.32339867 |
| 60 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.30713799 |
| 61 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.29502587 |
| 62 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.28883768 |
| 63 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.28883768 |
| 64 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.28027179 |
| 65 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.26440338 |
| 66 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.25729888 |
| 67 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.25487368 |
| 68 | TP53_16413492_ChIP-PET_HCT116_Human | 1.25074893 |
| 69 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.23609995 |
| 70 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.22565932 |
| 71 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.21214298 |
| 72 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.21033225 |
| 73 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.20234834 |
| 74 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.19617405 |
| 75 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.17191820 |
| 76 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.17152241 |
| 77 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.15231284 |
| 78 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.14735105 |
| 79 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.14341178 |
| 80 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.13677679 |
| 81 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.13423606 |
| 82 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.12672161 |
| 83 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.12261093 |
| 84 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.12033992 |
| 85 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.11412211 |
| 86 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.11412211 |
| 87 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.10497448 |
| 88 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.10497448 |
| 89 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.09756591 |
| 90 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.08520128 |
| 91 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.08484627 |
| 92 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.08346464 |
| 93 | NCOR_22424771_ChIP-Seq_293T_Human | 1.07081170 |
| 94 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.06545867 |
| 95 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.05889649 |
| 96 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.05354642 |
| 97 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.04743790 |
| 98 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.04174291 |
| 99 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.03783348 |
| 100 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.03449001 |
| 101 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.02857860 |
| 102 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.02494168 |
| 103 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.02416964 |
| 104 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.02199823 |
| 105 | RXR_22108803_ChIP-Seq_LS180_Human | 1.01982870 |
| 106 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.01833765 |
| 107 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.00592316 |
| 108 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.00315870 |
| 109 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.99964395 |
| 110 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.99574188 |
| 111 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.99217086 |
| 112 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.99002362 |
| 113 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.97491230 |
| 114 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.93784554 |
| 115 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.92703226 |
| 116 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.89216392 |
| 117 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.86214382 |
| 118 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.82386392 |
| 119 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.80888242 |
| 120 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.78113403 |
| 121 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.77190686 |
| 122 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.76687242 |
| 123 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.75801527 |
| 124 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.75754621 |
| 125 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.73976269 |
| 126 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.72922100 |
| 127 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.72115803 |
| 128 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.72115803 |
| 129 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.71839764 |
| 130 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.71664819 |
| 131 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.71443184 |
| 132 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.71273641 |
| 133 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.70030788 |
| 134 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.68001649 |
| 135 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.67317137 |
| 136 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.66967049 |
| 137 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.65872610 |
| 138 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.65860863 |
| 139 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.65768091 |
| 140 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.65609774 |
| 141 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.60758044 |
| 142 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.60362321 |
| 143 | AR_20517297_ChIP-Seq_VCAP_Human | 0.60065990 |
| 144 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.59427372 |
| 145 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.57664245 |
| 146 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.57117865 |
| 147 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.56820182 |
| 148 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.55311496 |
| 149 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.55079559 |
| 150 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.55015547 |
| 151 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.54631588 |
| 152 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.54572777 |
| 153 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.54394030 |
| 154 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.53988566 |
| 155 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.50645133 |
| 156 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.49336778 |
| 157 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.49224390 |
| 158 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.48912237 |
| 159 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.48796302 |
| 160 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.48719670 |
| 161 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.48127527 |
| 162 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.47542412 |
| 163 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.47034294 |
| 164 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.46722572 |
| 165 | GATA1_19941826_ChIP-Seq_K562_Human | 0.45982230 |
| 166 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.45782639 |
| 167 | * STAT1_17558387_ChIP-Seq_HELA_Human | 0.45771911 |
| 168 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.45745813 |
| 169 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.45587732 |
| 170 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.45508979 |
| 171 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.45432387 |
| 172 | CBP_21632823_ChIP-Seq_H3396_Human | 0.45275097 |
| 173 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.44938457 |
| 174 | GATA2_19941826_ChIP-Seq_K562_Human | 0.44557844 |
| 175 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.43220303 |
| 176 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.42672276 |
| 177 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.42349204 |
| 178 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.42315281 |
| 179 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.42190981 |
| 180 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.41745266 |
| 181 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.41457589 |
| 182 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.41205129 |
| 183 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.40581508 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.09039687 |
| 2 | MP0005360_urolithiasis | 7.60077803 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.18926869 |
| 4 | MP0005365_abnormal_bile_salt | 5.98207593 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.14556447 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.07216560 |
| 7 | MP0003252_abnormal_bile_duct | 3.77841839 |
| 8 | MP0001501_abnormal_sleep_pattern | 3.65340019 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.40623713 |
| 10 | MP0009840_abnormal_foam_cell | 3.11956334 |
| 11 | MP0005083_abnormal_biliary_tract | 2.92697685 |
| 12 | MP0005332_abnormal_amino_acid | 2.87572983 |
| 13 | MP0003195_calcinosis | 2.85193173 |
| 14 | MP0001666_abnormal_nutrient_absorption | 2.74895926 |
| 15 | MP0004885_abnormal_endolymph | 2.40641230 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.36131459 |
| 17 | MP0004019_abnormal_vitamin_homeostasis | 2.24868781 |
| 18 | MP0004147_increased_porphyrin_level | 2.23073578 |
| 19 | MP0001485_abnormal_pinna_reflex | 2.13777517 |
| 20 | MP0002138_abnormal_hepatobiliary_system | 2.07237511 |
| 21 | MP0000609_abnormal_liver_physiology | 2.06605573 |
| 22 | MP0002118_abnormal_lipid_homeostasis | 2.06113826 |
| 23 | MP0003868_abnormal_feces_composition | 2.02627776 |
| 24 | MP0005319_abnormal_enzyme/_coenzyme | 1.84560865 |
| 25 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.70369321 |
| 26 | MP0004742_abnormal_vestibular_system | 1.56427140 |
| 27 | MP0003879_abnormal_hair_cell | 1.56422445 |
| 28 | MP0001764_abnormal_homeostasis | 1.54469259 |
| 29 | MP0009643_abnormal_urine_homeostasis | 1.53216498 |
| 30 | MP0005451_abnormal_body_composition | 1.43116354 |
| 31 | MP0005551_abnormal_eye_electrophysiolog | 1.40006546 |
| 32 | MP0001986_abnormal_taste_sensitivity | 1.36658777 |
| 33 | MP0005646_abnormal_pituitary_gland | 1.35905535 |
| 34 | MP0009697_abnormal_copulation | 1.35387189 |
| 35 | MP0003186_abnormal_redox_activity | 1.29151349 |
| 36 | MP0005645_abnormal_hypothalamus_physiol | 1.28132574 |
| 37 | MP0003011_delayed_dark_adaptation | 1.25992678 |
| 38 | MP0003656_abnormal_erythrocyte_physiolo | 1.25803736 |
| 39 | MP0000427_abnormal_hair_cycle | 1.25398529 |
| 40 | MP0003183_abnormal_peptide_metabolism | 1.24669054 |
| 41 | MP0001968_abnormal_touch/_nociception | 1.22332214 |
| 42 | MP0002876_abnormal_thyroid_physiology | 1.21850336 |
| 43 | MP0003646_muscle_fatigue | 1.21033223 |
| 44 | MP0004043_abnormal_pH_regulation | 1.16283486 |
| 45 | MP0008877_abnormal_DNA_methylation | 1.15052654 |
| 46 | MP0005647_abnormal_sex_gland | 1.13161829 |
| 47 | MP0005636_abnormal_mineral_homeostasis | 1.12796563 |
| 48 | MP0000598_abnormal_liver_morphology | 1.12542494 |
| 49 | MP0005187_abnormal_penis_morphology | 1.08303785 |
| 50 | MP0003705_abnormal_hypodermis_morpholog | 1.07758523 |
| 51 | MP0009764_decreased_sensitivity_to | 1.06795189 |
| 52 | MP0000631_abnormal_neuroendocrine_gland | 1.06606721 |
| 53 | MP0000681_abnormal_thyroid_gland | 1.05342314 |
| 54 | MP0008004_abnormal_stomach_pH | 1.03481238 |
| 55 | MP0001664_abnormal_digestion | 1.03176050 |
| 56 | MP0000604_amyloidosis | 1.02761397 |
| 57 | MP0003890_abnormal_embryonic-extraembry | 1.01023017 |
| 58 | MP0001963_abnormal_hearing_physiology | 1.00838317 |
| 59 | MP0000026_abnormal_inner_ear | 0.99125918 |
| 60 | MP0002102_abnormal_ear_morphology | 0.96210050 |
| 61 | MP0002254_reproductive_system_inflammat | 0.94462840 |
| 62 | MP0009763_increased_sensitivity_to | 0.92057495 |
| 63 | MP0009642_abnormal_blood_homeostasis | 0.90333758 |
| 64 | MP0006036_abnormal_mitochondrial_physio | 0.88231117 |
| 65 | MP0002272_abnormal_nervous_system | 0.86831627 |
| 66 | MP0008469_abnormal_protein_level | 0.85602930 |
| 67 | MP0001756_abnormal_urination | 0.83812951 |
| 68 | MP0005084_abnormal_gallbladder_morpholo | 0.83164925 |
| 69 | MP0002736_abnormal_nociception_after | 0.82884339 |
| 70 | MP0000538_abnormal_urinary_bladder | 0.81513559 |
| 71 | MP0004484_altered_response_of | 0.81488779 |
| 72 | MP0005408_hypopigmentation | 0.80695924 |
| 73 | MP0009745_abnormal_behavioral_response | 0.80344680 |
| 74 | MP0010368_abnormal_lymphatic_system | 0.80339161 |
| 75 | MP0003136_yellow_coat_color | 0.78069551 |
| 76 | MP0002735_abnormal_chemical_nociception | 0.75777506 |
| 77 | MP0002078_abnormal_glucose_homeostasis | 0.74163307 |
| 78 | MP0009053_abnormal_anal_canal | 0.74052230 |
| 79 | MP0009765_abnormal_xenobiotic_induced | 0.73552746 |
| 80 | MP0002229_neurodegeneration | 0.71282173 |
| 81 | MP0004924_abnormal_behavior | 0.71153020 |
| 82 | MP0005386_behavior/neurological_phenoty | 0.71153020 |
| 83 | MP0005376_homeostasis/metabolism_phenot | 0.71075492 |
| 84 | MP0005220_abnormal_exocrine_pancreas | 0.70810733 |
| 85 | MP0002557_abnormal_social/conspecific_i | 0.70503937 |
| 86 | MP0008995_early_reproductive_senescence | 0.68489414 |
| 87 | MP0003045_fibrosis | 0.68282602 |
| 88 | MP0002909_abnormal_adrenal_gland | 0.68062083 |
| 89 | MP0005535_abnormal_body_temperature | 0.67989071 |
| 90 | MP0005174_abnormal_tail_pigmentation | 0.67905678 |
| 91 | MP0001663_abnormal_digestive_system | 0.66547677 |
| 92 | MP0003329_amyloid_beta_deposits | 0.66530740 |
| 93 | MP0005670_abnormal_white_adipose | 0.66291808 |
| 94 | MP0004130_abnormal_muscle_cell | 0.65882887 |
| 95 | MP0008775_abnormal_heart_ventricle | 0.65120638 |
| 96 | MP0000372_irregular_coat_pigmentation | 0.64942598 |
| 97 | MP0000569_abnormal_digit_pigmentation | 0.64666680 |
| 98 | MP0003787_abnormal_imprinting | 0.64392620 |
| 99 | MP0003690_abnormal_glial_cell | 0.64349721 |
| 100 | MP0002136_abnormal_kidney_physiology | 0.63854247 |
| 101 | MP0005389_reproductive_system_phenotype | 0.63188576 |
| 102 | MP0000678_abnormal_parathyroid_gland | 0.63001784 |
| 103 | MP0002971_abnormal_brown_adipose | 0.62649273 |
| 104 | MP0005253_abnormal_eye_physiology | 0.62643184 |
| 105 | MP0002638_abnormal_pupillary_reflex | 0.61821812 |
| 106 | MP0001661_extended_life_span | 0.61589606 |
| 107 | MP0004133_heterotaxia | 0.60222882 |
| 108 | MP0005334_abnormal_fat_pad | 0.60024268 |
| 109 | MP0003638_abnormal_response/metabolism_ | 0.60018498 |
| 110 | MP0010678_abnormal_skin_adnexa | 0.59083702 |
| 111 | MP0000383_abnormal_hair_follicle | 0.58610102 |
| 112 | MP0005266_abnormal_metabolism | 0.57434920 |
| 113 | MP0001486_abnormal_startle_reflex | 0.57141898 |
| 114 | MP0005310_abnormal_salivary_gland | 0.56151390 |
| 115 | MP0006035_abnormal_mitochondrial_morpho | 0.55692434 |
| 116 | MP0003698_abnormal_male_reproductive | 0.54913856 |
| 117 | MP0000639_abnormal_adrenal_gland | 0.54292585 |
| 118 | MP0004145_abnormal_muscle_electrophysio | 0.53912757 |
| 119 | MP0004782_abnormal_surfactant_physiolog | 0.52633139 |
| 120 | MP0001984_abnormal_olfaction | 0.52583716 |
| 121 | MP0003075_altered_response_to | 0.52333284 |
| 122 | MP0001919_abnormal_reproductive_system | 0.51646263 |
| 123 | MP0003953_abnormal_hormone_level | 0.49450643 |
| 124 | MP0005448_abnormal_energy_balance | 0.49288451 |
| 125 | MP0005058_abnormal_lysosome_morphology | 0.49236997 |
| 126 | MP0010234_abnormal_vibrissa_follicle | 0.49162824 |
| 127 | MP0005395_other_phenotype | 0.45768269 |
| 128 | MP0002796_impaired_skin_barrier | 0.45277842 |
| 129 | MP0005166_decreased_susceptibility_to | 0.43932167 |
| 130 | MP0008874_decreased_physiological_sensi | 0.42925073 |
| 131 | MP0005464_abnormal_platelet_physiology | 0.42143777 |
| 132 | MP0008872_abnormal_physiological_respon | 0.41156634 |
| 133 | MP0002928_abnormal_bile_duct | 0.41011789 |
| 134 | MP0008873_increased_physiological_sensi | 0.40398355 |
| 135 | MP0001765_abnormal_ion_homeostasis | 0.40208200 |
| 136 | MP0002822_catalepsy | 0.38799498 |
| 137 | MP0005666_abnormal_adipose_tissue | 0.37706896 |
| 138 | MP0002168_other_aberrant_phenotype | 0.36725453 |
| 139 | MP0004264_abnormal_extraembryonic_tissu | 0.36453004 |
| 140 | MP0003436_decreased_susceptibility_to | 0.34314375 |
| 141 | MP0002837_dystrophic_cardiac_calcinosis | 0.34171915 |
| 142 | MP0000230_abnormal_systemic_arterial | 0.34148190 |
| 143 | MP0003718_maternal_effect | 0.32965170 |
| 144 | MP0003724_increased_susceptibility_to | 0.31212896 |
| 145 | MP0005248_abnormal_Harderian_gland | 0.31019222 |
| 146 | MP0009115_abnormal_fat_cell | 0.30713448 |
| 147 | MP0006082_CNS_inflammation | 0.30560636 |
| 148 | MP0002135_abnormal_kidney_morphology | 0.30280486 |
| 149 | MP0009384_cardiac_valve_regurgitation | 0.29451158 |
| 150 | MP0000579_abnormal_nail_morphology | 0.29410133 |
| 151 | MP0000249_abnormal_blood_vessel | 0.27784121 |
| 152 | MP0009672_abnormal_birth_weight | 0.27252294 |
| 153 | MP0001845_abnormal_inflammatory_respons | 0.27211790 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.19223560 |
| 2 | Deep venous thrombosis (HP:0002625) | 7.04513631 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 7.00047621 |
| 4 | Congenital sensorineural hearing impairment (HP:0008527) | 6.52324282 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.51041216 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 6.12233105 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 6.10366442 |
| 8 | Xanthomatosis (HP:0000991) | 6.01484092 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.20422964 |
| 10 | Complement deficiency (HP:0004431) | 5.02672199 |
| 11 | Hypothermia (HP:0002045) | 4.99679297 |
| 12 | Hyperammonemia (HP:0001987) | 4.57789473 |
| 13 | Hypolipoproteinemia (HP:0010981) | 4.50907062 |
| 14 | Hyperthyroidism (HP:0000836) | 4.46652972 |
| 15 | Joint hemorrhage (HP:0005261) | 4.45752982 |
| 16 | Hyperglycinemia (HP:0002154) | 4.37744884 |
| 17 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.36548170 |
| 18 | Ketosis (HP:0001946) | 4.29689654 |
| 19 | Abnormality of the common coagulation pathway (HP:0010990) | 4.21818273 |
| 20 | Epidermoid cyst (HP:0200040) | 4.18729293 |
| 21 | Hyperglycinuria (HP:0003108) | 4.18629187 |
| 22 | * Aplasia/Hypoplasia of the abdominal wall musculature (HP:0010318) | 4.17989559 |
| 23 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.13853053 |
| 24 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.11005021 |
| 25 | Fat malabsorption (HP:0002630) | 4.05450669 |
| 26 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.05441258 |
| 27 | Abnormality of glycine metabolism (HP:0010895) | 4.04559807 |
| 28 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.04559807 |
| 29 | Abnormality of methionine metabolism (HP:0010901) | 3.94568998 |
| 30 | Hypoalphalipoproteinemia (HP:0003233) | 3.87766071 |
| 31 | Hypoglycemic coma (HP:0001325) | 3.74731484 |
| 32 | Delayed CNS myelination (HP:0002188) | 3.67717830 |
| 33 | Abnormality of complement system (HP:0005339) | 3.62623607 |
| 34 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.61896872 |
| 35 | Conjugated hyperbilirubinemia (HP:0002908) | 3.58997937 |
| 36 | Thyroid carcinoma (HP:0002890) | 3.55895701 |
| 37 | Abnormality of the intrinsic pathway (HP:0010989) | 3.55823222 |
| 38 | Hypercholesterolemia (HP:0003124) | 3.41879001 |
| 39 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.35818938 |
| 40 | Hyperventilation (HP:0002883) | 3.34893526 |
| 41 | Hyperbilirubinemia (HP:0002904) | 3.24204227 |
| 42 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.22674103 |
| 43 | Ketoacidosis (HP:0001993) | 3.21894005 |
| 44 | Abnormality of nucleobase metabolism (HP:0010932) | 3.13069592 |
| 45 | Decreased circulating renin level (HP:0003351) | 3.12341163 |
| 46 | Pancreatic cysts (HP:0001737) | 3.10143524 |
| 47 | Steatorrhea (HP:0002570) | 3.03785773 |
| 48 | Abnormality of serum amino acid levels (HP:0003112) | 2.94391720 |
| 49 | Abnormality of purine metabolism (HP:0004352) | 2.88655952 |
| 50 | Hepatocellular carcinoma (HP:0001402) | 2.85619177 |
| 51 | Metabolic acidosis (HP:0001942) | 2.84672977 |
| 52 | Gout (HP:0001997) | 2.84300416 |
| 53 | Congenital stationary night blindness (HP:0007642) | 2.84199545 |
| 54 | Spontaneous abortion (HP:0005268) | 2.76740484 |
| 55 | Lethargy (HP:0001254) | 2.76202637 |
| 56 | True hermaphroditism (HP:0010459) | 2.74808732 |
| 57 | Vascular calcification (HP:0004934) | 2.74500153 |
| 58 | Hyperpituitarism (HP:0010514) | 2.73476948 |
| 59 | Pancreatic fibrosis (HP:0100732) | 2.70450051 |
| 60 | Myocardial infarction (HP:0001658) | 2.68479575 |
| 61 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.63734818 |
| 62 | Dicarboxylic aciduria (HP:0003215) | 2.63734818 |
| 63 | Systemic lupus erythematosus (HP:0002725) | 2.62362879 |
| 64 | Hypochromic microcytic anemia (HP:0004840) | 2.62086155 |
| 65 | Abnormality of the renal cortex (HP:0011035) | 2.61337470 |
| 66 | Hyperactive renin-angiotensin system (HP:0000841) | 2.56510222 |
| 67 | Skin nodule (HP:0200036) | 2.55761164 |
| 68 | Metabolic alkalosis (HP:0200114) | 2.50836792 |
| 69 | Irritability (HP:0000737) | 2.49617510 |
| 70 | * Goiter (HP:0000853) | 2.46404220 |
| 71 | Cardiovascular calcification (HP:0011915) | 2.43066769 |
| 72 | Abnormality of renin-angiotensin system (HP:0000847) | 2.42780234 |
| 73 | Attenuation of retinal blood vessels (HP:0007843) | 2.42611299 |
| 74 | Malnutrition (HP:0004395) | 2.41741828 |
| 75 | Abnormality of vitamin B metabolism (HP:0004340) | 2.40323785 |
| 76 | Spastic diplegia (HP:0001264) | 2.38873481 |
| 77 | * Hypothyroidism (HP:0000821) | 2.36316122 |
| 78 | Cerebral edema (HP:0002181) | 2.36309917 |
| 79 | Acanthocytosis (HP:0001927) | 2.36013914 |
| 80 | Abnormality of cochlea (HP:0000375) | 2.34820430 |
| 81 | Hypoglycemic seizures (HP:0002173) | 2.32953631 |
| 82 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.32881353 |
| 83 | Abnormal gallbladder morphology (HP:0012437) | 2.32644992 |
| 84 | Glomerulonephritis (HP:0000099) | 2.32609547 |
| 85 | Neonatal onset (HP:0003623) | 2.32322442 |
| 86 | Abnormality of urine glucose concentration (HP:0011016) | 2.29015909 |
| 87 | Glycosuria (HP:0003076) | 2.29015909 |
| 88 | Mitral stenosis (HP:0001718) | 2.28014090 |
| 89 | Renal cortical cysts (HP:0000803) | 2.27958282 |
| 90 | Cholelithiasis (HP:0001081) | 2.27532988 |
| 91 | Abnormality of vitamin metabolism (HP:0100508) | 2.27401089 |
| 92 | Type II lissencephaly (HP:0007260) | 2.26416402 |
| 93 | Amyloidosis (HP:0011034) | 2.25432561 |
| 94 | Abnormal gallbladder physiology (HP:0012438) | 2.23369008 |
| 95 | Cholecystitis (HP:0001082) | 2.23369008 |
| 96 | Sensorimotor neuropathy (HP:0007141) | 2.23035066 |
| 97 | Esophageal varix (HP:0002040) | 2.21511034 |
| 98 | Abolished electroretinogram (ERG) (HP:0000550) | 2.21366097 |
| 99 | Generalized aminoaciduria (HP:0002909) | 2.20046173 |
| 100 | Late onset (HP:0003584) | 2.19600418 |
| 101 | Hyperaldosteronism (HP:0000859) | 2.18402783 |
| 102 | Vomiting (HP:0002013) | 2.17330739 |
| 103 | Alkalosis (HP:0001948) | 2.16925096 |
| 104 | Fair hair (HP:0002286) | 2.15957067 |
| 105 | Molar tooth sign on MRI (HP:0002419) | 2.15916266 |
| 106 | Abnormality of midbrain morphology (HP:0002418) | 2.15916266 |
| 107 | Pancreatitis (HP:0001733) | 2.13361529 |
| 108 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.10510466 |
| 109 | Nephronophthisis (HP:0000090) | 2.10487314 |
| 110 | Cystic liver disease (HP:0006706) | 2.10472504 |
| 111 | Hydroxyprolinuria (HP:0003080) | 2.10312120 |
| 112 | Abnormality of proline metabolism (HP:0010907) | 2.10312120 |
| 113 | Pigmentary retinal degeneration (HP:0001146) | 2.09292012 |
| 114 | Medial flaring of the eyebrow (HP:0010747) | 2.09264024 |
| 115 | Enlarged kidneys (HP:0000105) | 2.05993575 |
| 116 | Polyuria (HP:0000103) | 2.05454901 |
| 117 | Rickets (HP:0002748) | 2.03515145 |
| 118 | Polydipsia (HP:0001959) | 2.03154745 |
| 119 | Abnormal drinking behavior (HP:0030082) | 2.03154745 |
| 120 | Chronic hepatic failure (HP:0100626) | 2.02718186 |
| 121 | Thyroid-stimulating hormone excess (HP:0002925) | 2.00536419 |
| 122 | Abnormality of the renal medulla (HP:0100957) | 2.00465218 |
| 123 | Abnormal urine output (HP:0012590) | 2.00270496 |
| 124 | Menorrhagia (HP:0000132) | 2.00241294 |
| 125 | Large for gestational age (HP:0001520) | 1.99784329 |
| 126 | Brushfield spots (HP:0001088) | 1.99700042 |
| 127 | Thrombophlebitis (HP:0004418) | 1.97103518 |
| 128 | Delayed epiphyseal ossification (HP:0002663) | 1.97054522 |
| 129 | Gingival bleeding (HP:0000225) | 1.96537555 |
| 130 | Proximal tubulopathy (HP:0000114) | 1.96239047 |
| 131 | Decreased central vision (HP:0007663) | 1.96237500 |
| 132 | Bile duct proliferation (HP:0001408) | 1.93476723 |
| 133 | Abnormal biliary tract physiology (HP:0012439) | 1.93476723 |
| 134 | Opisthotonus (HP:0002179) | 1.93473012 |
| 135 | Chronic diarrhea (HP:0002028) | 1.91419533 |
| 136 | Stomach cancer (HP:0012126) | 1.91377777 |
| 137 | Abnormal hair laboratory examination (HP:0003328) | 1.91061165 |
| 138 | Hyperuricemia (HP:0002149) | 1.91018185 |
| 139 | Increased purine levels (HP:0004368) | 1.91018185 |
| 140 | Chorioretinal atrophy (HP:0000533) | 1.90617578 |
| 141 | Abnormality of the gallbladder (HP:0005264) | 1.89114113 |
| 142 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.88483361 |
| 143 | Hemorrhage of the eye (HP:0011885) | 1.88432565 |
| 144 | Abnormality of iron homeostasis (HP:0011031) | 1.88428657 |
| 145 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.85666104 |
| 146 | Abnormal cartilage morphology (HP:0002763) | 1.85116507 |
| 147 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.84545785 |
| 148 | Pili torti (HP:0003777) | 1.84296568 |
| 149 | Nephritis (HP:0000123) | 1.83730142 |
| 150 | Gaze-evoked nystagmus (HP:0000640) | 1.83725470 |
| 151 | Abnormality of renal excretion (HP:0011036) | 1.83223708 |
| 152 | Hypokalemia (HP:0002900) | 1.82818625 |
| 153 | Abnormality of alanine metabolism (HP:0010916) | 1.78544077 |
| 154 | Hyperalaninemia (HP:0003348) | 1.78544077 |
| 155 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.78544077 |
| 156 | Morphological abnormality of the inner ear (HP:0011390) | 1.77255490 |
| 157 | Amelogenesis imperfecta (HP:0000705) | 1.76107506 |
| 158 | Methylmalonic aciduria (HP:0012120) | 1.74618600 |
| 159 | Tubular atrophy (HP:0000092) | 1.73910322 |
| 160 | * Coarse facial features (HP:0000280) | 1.70264868 |
| 161 | Generalized hypopigmentation of hair (HP:0011358) | 1.69977465 |
| 162 | Abnormality of potassium homeostasis (HP:0011042) | 1.69722968 |
| 163 | Hypomagnesemia (HP:0002917) | 1.64445920 |
| 164 | Abnormality of chloride homeostasis (HP:0011422) | 1.64411227 |
| 165 | Inability to walk (HP:0002540) | 1.63832057 |
| 166 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.61056516 |
| 167 | Confusion (HP:0001289) | 1.60351732 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.03068606 |
| 2 | ERN1 | 4.38845131 |
| 3 | SIK1 | 4.24873459 |
| 4 | FGFR4 | 4.21317821 |
| 5 | ACVR1B | 3.82211104 |
| 6 | ADRBK2 | 2.89551365 |
| 7 | CASK | 2.88873223 |
| 8 | ERBB4 | 2.85824025 |
| 9 | TAOK3 | 2.75510446 |
| 10 | BMPR1B | 2.62696885 |
| 11 | INSRR | 2.51108675 |
| 12 | TRIB3 | 2.43360068 |
| 13 | PKN2 | 2.28789408 |
| 14 | MST1R | 2.24123792 |
| 15 | DAPK2 | 2.12859285 |
| 16 | MAP4K2 | 2.09618087 |
| 17 | NUAK1 | 2.09070656 |
| 18 | STK39 | 2.05478523 |
| 19 | MAP2K4 | 1.98191188 |
| 20 | FRK | 1.72138333 |
| 21 | PTK6 | 1.69829930 |
| 22 | FGFR2 | 1.66377884 |
| 23 | PIK3CG | 1.63831805 |
| 24 | MAPK11 | 1.59564558 |
| 25 | FLT3 | 1.59434167 |
| 26 | LATS1 | 1.56895241 |
| 27 | ZAK | 1.54595445 |
| 28 | EPHA2 | 1.46815759 |
| 29 | TYK2 | 1.39299539 |
| 30 | ERBB3 | 1.26945747 |
| 31 | TLK1 | 1.24946068 |
| 32 | NEK9 | 1.23584452 |
| 33 | ABL2 | 1.22988109 |
| 34 | KDR | 1.22308580 |
| 35 | EPHB1 | 1.21680691 |
| 36 | TNIK | 1.19344814 |
| 37 | JAK2 | 1.18367284 |
| 38 | PRKCE | 1.16139068 |
| 39 | MAP3K7 | 1.11743612 |
| 40 | TBK1 | 1.10997851 |
| 41 | MAPK13 | 1.09984359 |
| 42 | STK38L | 1.09586516 |
| 43 | GRK6 | 1.08211964 |
| 44 | MAP3K4 | 1.04379115 |
| 45 | BRSK2 | 1.02555954 |
| 46 | NLK | 1.02403055 |
| 47 | MST4 | 1.01744554 |
| 48 | PRKAA2 | 0.98608015 |
| 49 | TXK | 0.98551811 |
| 50 | MAP2K3 | 0.98181359 |
| 51 | PINK1 | 0.98057268 |
| 52 | PRKCZ | 0.97778110 |
| 53 | RIPK1 | 0.97619628 |
| 54 | ADRBK1 | 0.95679100 |
| 55 | MET | 0.94629369 |
| 56 | MAP3K10 | 0.90248596 |
| 57 | MAP3K3 | 0.89901954 |
| 58 | MAPK4 | 0.88133044 |
| 59 | ERBB2 | 0.85431125 |
| 60 | JAK1 | 0.85196784 |
| 61 | EIF2AK3 | 0.85135055 |
| 62 | MAP3K14 | 0.80749680 |
| 63 | PTK2 | 0.79974067 |
| 64 | NTRK3 | 0.78066827 |
| 65 | MAP2K6 | 0.77694625 |
| 66 | MAP3K11 | 0.77280974 |
| 67 | MKNK2 | 0.77116871 |
| 68 | CAMK1D | 0.76702719 |
| 69 | MAPK15 | 0.76552608 |
| 70 | TIE1 | 0.74864337 |
| 71 | IRAK3 | 0.74119504 |
| 72 | PRKACG | 0.73988027 |
| 73 | MAPKAPK3 | 0.73685642 |
| 74 | TEC | 0.73479733 |
| 75 | RET | 0.71351212 |
| 76 | MAP2K1 | 0.69021762 |
| 77 | DYRK1B | 0.68583932 |
| 78 | KIT | 0.67999935 |
| 79 | SGK3 | 0.66883168 |
| 80 | GSK3A | 0.66770220 |
| 81 | CSK | 0.66767678 |
| 82 | WNK4 | 0.66303182 |
| 83 | CAMK2G | 0.64849841 |
| 84 | MAPK12 | 0.64386121 |
| 85 | EPHA3 | 0.63385725 |
| 86 | PRKAA1 | 0.61481528 |
| 87 | PDK4 | 0.61296586 |
| 88 | PDK3 | 0.61296586 |
| 89 | PDPK1 | 0.61134147 |
| 90 | TGFBR2 | 0.60855096 |
| 91 | IRAK1 | 0.60584032 |
| 92 | MAP2K2 | 0.60205322 |
| 93 | AKT3 | 0.59169081 |
| 94 | RPS6KA5 | 0.58946251 |
| 95 | CAMKK2 | 0.58059102 |
| 96 | STK3 | 0.56935837 |
| 97 | CDK6 | 0.56468543 |
| 98 | PDK2 | 0.55907678 |
| 99 | PHKG2 | 0.54344365 |
| 100 | PHKG1 | 0.54344365 |
| 101 | TRIM28 | 0.53081537 |
| 102 | TRPM7 | 0.52969100 |
| 103 | EPHA4 | 0.52494681 |
| 104 | PRKACA | 0.52160315 |
| 105 | TGFBR1 | 0.52112152 |
| 106 | NEK1 | 0.51199034 |
| 107 | NME1 | 0.51155988 |
| 108 | MAP3K2 | 0.50807589 |
| 109 | CSNK1A1 | 0.50715288 |
| 110 | BCR | 0.50470110 |
| 111 | PAK3 | 0.50098337 |
| 112 | PLK2 | 0.49678313 |
| 113 | CSNK1G2 | 0.48358651 |
| 114 | CAMK2A | 0.48185702 |
| 115 | PRKCA | 0.46364460 |
| 116 | PRKCQ | 0.44803111 |
| 117 | DMPK | 0.44114926 |
| 118 | IKBKE | 0.43791049 |
| 119 | FER | 0.43665939 |
| 120 | MUSK | 0.42757977 |
| 121 | IGF1R | 0.41858216 |
| 122 | PRKG1 | 0.40739263 |
| 123 | ITK | 0.40588951 |
| 124 | MYLK | 0.40358644 |
| 125 | SGK223 | 0.40093048 |
| 126 | SGK494 | 0.40093048 |
| 127 | CHUK | 0.39527821 |
| 128 | FGFR3 | 0.39145713 |
| 129 | PIK3CA | 0.38616786 |
| 130 | SGK2 | 0.38525518 |
| 131 | KSR2 | 0.38088065 |
| 132 | CSNK1G1 | 0.37950604 |
| 133 | PDK1 | 0.37360860 |
| 134 | PKN1 | 0.35990813 |
| 135 | EGFR | 0.35937925 |
| 136 | MAPK7 | 0.35427532 |
| 137 | PRKG2 | 0.34990565 |
| 138 | MAP2K7 | 0.34910234 |
| 139 | GRK1 | 0.34065663 |
| 140 | MAP3K5 | 0.34011474 |
| 141 | PRKCG | 0.33527086 |
| 142 | WNK3 | 0.32914103 |
| 143 | LRRK2 | 0.32910390 |
| 144 | ICK | 0.32380024 |
| 145 | IKBKB | 0.32048993 |
| 146 | IRAK2 | 0.32026559 |
| 147 | TAOK2 | 0.31992561 |
| 148 | CAMK1G | 0.31886707 |
| 149 | PTK2B | 0.31051169 |
| 150 | MAP3K1 | 0.30256715 |
| 151 | MAP3K13 | 0.29870380 |
| 152 | OXSR1 | 0.29786638 |
| 153 | MTOR | 0.29689702 |
| 154 | EPHB2 | 0.29455966 |
| 155 | CSNK1G3 | 0.27849511 |
| 156 | STK24 | 0.27393514 |
| 157 | PNCK | 0.26490021 |
| 158 | LMTK2 | 0.24473695 |
| 159 | PLK4 | 0.23696246 |
| 160 | CSNK1A1L | 0.23670274 |
| 161 | ABL1 | 0.23148765 |
| 162 | CSF1R | 0.22504722 |
| 163 | CSNK1D | 0.22466730 |
| 164 | CAMK2D | 0.22373347 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.33515579 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.42022471 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.41007926 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.28970322 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.01912217 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.68173102 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.63246699 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.62902869 |
| 9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.55401919 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.50925047 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.48509520 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.46127159 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.31638837 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.19296761 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.18081634 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.07563616 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.99601224 |
| 18 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.97875325 |
| 19 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.97199109 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.86013734 |
| 21 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.83327385 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.81036047 |
| 23 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.78186657 |
| 24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.76055737 |
| 25 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.69855097 |
| 26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.69670939 |
| 27 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.68298249 |
| 28 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.68180277 |
| 29 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.64688257 |
| 30 | Bile secretion_Homo sapiens_hsa04976 | 1.63922478 |
| 31 | Retinol metabolism_Homo sapiens_hsa00830 | 1.62747601 |
| 32 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.58620248 |
| 33 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.58130862 |
| 34 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.58122267 |
| 35 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.57658794 |
| 36 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.56906298 |
| 37 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.48679093 |
| 38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.45314015 |
| 39 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.35596767 |
| 40 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.31862151 |
| 41 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.31507197 |
| 42 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.30185199 |
| 43 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.28677350 |
| 44 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.27638783 |
| 45 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.24128734 |
| 46 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.22716400 |
| 47 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.17377290 |
| 48 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.16352711 |
| 49 | Carbon metabolism_Homo sapiens_hsa01200 | 1.15585952 |
| 50 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.13431498 |
| 51 | ABC transporters_Homo sapiens_hsa02010 | 1.11328519 |
| 52 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.08726353 |
| 53 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.08362129 |
| 54 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.03327113 |
| 55 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.99988927 |
| 56 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.99526266 |
| 57 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.98571204 |
| 58 | Phototransduction_Homo sapiens_hsa04744 | 0.96226010 |
| 59 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.95091218 |
| 60 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.88421054 |
| 61 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.86698398 |
| 62 | Sulfur relay system_Homo sapiens_hsa04122 | 0.86649411 |
| 63 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.86087129 |
| 64 | Lysine degradation_Homo sapiens_hsa00310 | 0.80008470 |
| 65 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.77839011 |
| 66 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.77713979 |
| 67 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.72735661 |
| 68 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.70917880 |
| 69 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.68280380 |
| 70 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.66562699 |
| 71 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.64655387 |
| 72 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.64260204 |
| 73 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.63727984 |
| 74 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.56216884 |
| 75 | Asthma_Homo sapiens_hsa05310 | 0.55215995 |
| 76 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.54994063 |
| 77 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.54808266 |
| 78 | Taste transduction_Homo sapiens_hsa04742 | 0.48937209 |
| 79 | Nicotine addiction_Homo sapiens_hsa05033 | 0.47554205 |
| 80 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.45903947 |
| 81 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45449380 |
| 82 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.45164526 |
| 83 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.42738097 |
| 84 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.42245814 |
| 85 | Insulin secretion_Homo sapiens_hsa04911 | 0.36721577 |
| 86 | Protein export_Homo sapiens_hsa03060 | 0.34481304 |
| 87 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.33005113 |
| 88 | Prion diseases_Homo sapiens_hsa05020 | 0.31391349 |
| 89 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.29804360 |
| 90 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.29531312 |
| 91 | Galactose metabolism_Homo sapiens_hsa00052 | 0.28168479 |
| 92 | * Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.27871511 |
| 93 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.27025676 |
| 94 | Allograft rejection_Homo sapiens_hsa05330 | 0.26346511 |
| 95 | Olfactory transduction_Homo sapiens_hsa04740 | 0.24528858 |
| 96 | Circadian rhythm_Homo sapiens_hsa04710 | 0.24402132 |
| 97 | Salivary secretion_Homo sapiens_hsa04970 | 0.23591131 |
| 98 | Insulin resistance_Homo sapiens_hsa04931 | 0.23043747 |
| 99 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.22719517 |
| 100 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.19921352 |
| 101 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.19221350 |
| 102 | Cocaine addiction_Homo sapiens_hsa05030 | 0.17869708 |
| 103 | Morphine addiction_Homo sapiens_hsa05032 | 0.15656227 |
| 104 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.14451445 |
| 105 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.14288075 |
| 106 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.14136096 |
| 107 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.12544705 |
| 108 | Circadian entrainment_Homo sapiens_hsa04713 | 0.10892213 |
| 109 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.09692418 |
| 110 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.07224137 |
| 111 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.00060102 |
| 112 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1968142 |
| 113 | Amoebiasis_Homo sapiens_hsa05146 | -0.1820236 |
| 114 | Hepatitis C_Homo sapiens_hsa05160 | -0.1785704 |
| 115 | Bladder cancer_Homo sapiens_hsa05219 | -0.1627318 |
| 116 | Lysosome_Homo sapiens_hsa04142 | -0.1612124 |
| 117 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1510675 |
| 118 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1405792 |
| 119 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1266004 |
| 120 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1196689 |
| 121 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1155912 |
| 122 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1142556 |
| 123 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1136567 |
| 124 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1031922 |
| 125 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0932570 |
| 126 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0869857 |
| 127 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0721648 |
| 128 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0328432 |
| 129 | Mineral absorption_Homo sapiens_hsa04978 | -0.0007687 |

